Brigitte L. Kieffer, PhD, is the new Scientific Director of the Douglas Institute Research Centre

Pierre Étienne is a psychiatrist in the geriatric psychiatry program of the Douglas Institute. He is interested in the early development of medication and in Alzheimer's Disease.

Marcelo Berlim is mainly interested in the study and treatment of depressive disorders with the use of state-of-the-art neuromodulation techniques.

Rob Whitley examines barriers and facilitators to recovery within both health services and the wider socio-cultural environment.

Norbert Schmitz is involved in biostatistics, psychiatric epidemiology and psychometrics.  

Bruno Giros characterizes the neurobiology of schizophrenia and develops improved genetic animal models of this illness.

Natasha Rajah, nvestigates how memory retrieval works in healthy young adults, and how it is affected by aging.

The research of Myra Piat focuses on housing for persons with serious mental illness and recovery from serious mental illness.

Howard Steiger contributed to the advancement of knowledge regarding causal mechanisms and clinical management of eating disorders.

Judes Poirier who had discovered a novel genetic risk factor that triggers the common form of Alzheimer’s disease, again made history in June.